Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Gerontol Geriatr Res. 2011;2011:628670. doi: 10.1155/2011/628670. Epub 2011 Aug 10.

Clinical pharmacology of chemotherapy agents in older people with cancer.

Author information

  • 1Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Abstract

Populations around the world are aging, and the associated increase in cancer incidence has led to the recognition of the importance of geriatric oncology. Chronological age is a poor determinant of pharmacological response to cancer chemotherapy agents. Age-associated changes in physiology and organ function have a significant impact on the clinical pharmacology of cancer chemotherapy agents used in cancer treatment. Altered response to medicines in older people is a consequence of changes in body composition, organ function, concomitant pathophysiology, multiple medications, genetic determinants of drug response, and patient's clinical status. These issues highlight the need to individualize the management of cancer in the older people with consideration of age-related changes in the clinical pharmacology of cancer drugs, analgesics, and adjunctive therapies.

PMID:
21845189
[PubMed]
PMCID:
PMC3154497
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Write to the Help Desk